TSLP and airway hyperresponsiveness: When they gave anti-TSLP monoclonal antibody, the DEHP enhanced airway inflammation, Th2 cytokines (IL-4, IL-5 and IL-13) production, and airway hyperresponsiveness were reduced via neutralized TSLP (29).